Listen to New Voices on Studs Terkel our partnership with 826CHI-here! Read the Story
Showing 1 - 2 of 2 results
Studs Terkel interviews two representatives from Abbott Laboratories: Richard Kasperson, V.P. of corporate regulatory affairs, and Dr. Robert Janicki, V.P. of corporate clinical research. The topic of conversation is the prescribed use of Cylert, which was a trade name for the drug Pemoline. Cylert was used to treat attention-deficit hyperactivity disorder (ADHD) and narcolepsy. Janicki and Kasperson respond to claims that the drug was overprescribed to school-aged children.
Philip Hilts, an author and journalist, discusses behavior modification and it advantages and dangers. He delves into B. F. Skinner and Ivan Pavlov's work and explains how behavior modification is used today. Hilts discusses cases used in prisons, schools, and workplaces. Hilts also talks about typical medications given to children who are said to experience hyperactivity.